Extracorporeal Carbon Dioxide Removal in Acute Respiratory Distress Syndrome: Physiologic Rationale and...

Area of Science:

• Critical Care Medicine
• Pulmonary Medicine
• Cardiopulmonary Support

Background:

• Acute respiratory distress syndrome (ARDS) presents significant morbidity and mortality.
• Mechanical ventilation, while life-saving, can worsen lung injury via excessive power delivery.
• Lung-protective ventilation strategies may not fully mitigate ventilator-induced lung injury (VILI).

Purpose of the Study:

• To evaluate the role of Extracorporeal carbon dioxide removal (ECCO2R) in enabling ultra-protective mechanical ventilation.
• To explore ECCO2R's potential to mitigate VILI by reducing ventilator power.
• To assess the feasibility and outcomes of ECCO2R in ARDS management.

Main Methods:

• ECCO2R involves removing CO2 at low extracorporeal blood flows (0.3-1.0 L/min) to decouple gas exchange from ventilation.
• Physiological studies demonstrated feasibility, but large randomized trials showed no survival benefit.
• Recent research suggests ARDS heterogeneity influences ECCO2R efficacy.

Main Results:

• Early studies confirmed ECCO2R feasibility for ultra-protective ventilation.
• Large trials did not demonstrate improved survival and noted complications like bleeding.
• Patient phenotypes (e.g., high driving pressure, hyperinflammation) may predict better response.

Conclusions:

• ECCO2R is not a universal ARDS therapy but a targeted physiological tool.
• Technological advancements are improving safety and feasibility.
• Future research should focus on phenotype-enriched trials and precision ventilation strategies.